Beleaguered Novo offers relief to investors, thanks to Wegovy pill
MarketWatch
Novo Nordisk’s stock jumped higher on Wednesday as the Danish drugmaker lifted its guidance on strong uptake of its weight-loss-drug pill that has been launched this year.
Read the full story
This is a short summary. The complete article is published by MarketWatch.
Headline and summary aggregated from public news feeds. For information only — not financial advice.